Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series

Tobias Else1, Antonio Marcondes Lerario1, Jessica Everett2

  • 1Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Abstract

Insights

Succinate dehydrogenase (SDHx) mutations are linked to rare tumors. This study found SDHx mutations in four patients with adrenocortical carcinoma (ACC), suggesting ACC may be a rare manifestation of SDHx-related tumor syndromes.

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Germline loss-of-function mutations in succinate dehydrogenase (SDHx) genes are associated with rare tumor syndromes like pheochromocytoma and paraganglioma.
  • Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex.

Observation:

  • This case series reports on four unrelated patients diagnosed with ACC who were found to harbor SDHx mutations.
  • All patients presented with Cushing syndrome and large adrenal masses confirmed as ACC.
  • Mutations were identified in SDHC or SDHA genes in the ACC specimens, with germline confirmation in three cases.

Findings:

  • Truncating mutations in SDHA or SDHC were observed in the ACC and/or germline of four unrelated patients.
  • Case 1 demonstrated familial inheritance of an SDHC mutation, with the affected father also having paraganglioma and renal cell carcinoma.
  • Evidence of loss of heterozygosity was noted in one ACC case, suggesting a potential role in tumorigenesis.

Implications:

  • The concurrence of ACC and pathogenic germline SDHx mutations is statistically improbable, suggesting a potential link.
  • These findings raise the possibility that ACC may represent a rare clinical manifestation of SDHx mutation syndromes.
  • Further research is warranted to elucidate the role of SDH deficiency in the pathogenesis of ACC.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K